Gene · 6582
Papers2,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of Mouse Organic Cation Transporter 2 for Nephro- and Peripheral Neurotoxicity Induced by Chemotherapeutic Treatment with Cisplatin. | Int J Mol Sci | 2023 | 37511245 | PubTator, text mining | PubMed |
| Comprehensive Analysis and Drug Modulation of Human Endogenous Retrovirus in Hepatocellular Carcinomas. | Cancers (Basel) | 2023 | 37509325 | PubTator, text mining | PubMed |
| Development of a new drug candidate for the inhibition of Lassa virus glycoprotein and nucleoprotein by modification of evodiamine as promising therapeutic agents. | Front Microbiol | 2023 | 37497547 | PubTator, text mining | PubMed |
| Natural fulvic acids inhibit non-small-cell lung cancer through the COX-2/PGE2/EP4 axis: In silico and in vivo assessments. | Heliyon | 2023 | 37484418 | PubTator, text mining | PubMed |
| Hypomagnesemia because of nedaplatin for cervical cancer: A case report. | J Gen Fam Med | 2023 | 37484120 | PubTator, text mining | PubMed |
| Urinary Kidney Injury Biomarkers Are Associated with Ischemia-Reperfusion Injury Severity in Kidney Allograft Recipients. | Clin Chem | 2023 | 37477911 | PubTator, text mining | PubMed |
| Research Methods and New Advances in Drug-Drug Interactions Mediated by Renal Transporters. | Molecules | 2023 | 37446913 | PubTator, text mining | PubMed |
| Cisplatin in Liver Cancer Therapy. | Int J Mol Sci | 2023 | 37446035 | PubTator, text mining | PubMed |
| Relationship between Adsorption and Toxicity of Nephrotoxic Drugs in Microphysiological Systems (MPS). | Micromachines (Basel) | 2023 | 37420994 | PubTator, text mining | PubMed |
| Position paper of the Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), and the Italian Study Group of Diabetes in pregnancy: Metformin use in pregnancy. | Acta Diabetol | 2023 | 37401946 | PubTator, text mining | PubMed |
| Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes. | Drug Des Devel Ther | 2023 | 37397787 | PubTator, text mining | PubMed |
| In silico analysis of the solute carrier (SLC) family in cancer indicates a link among DNA methylation, metabolic adaptation, drug response, and immune reactivity. | Front Pharmacol | 2023 | 37397501 | PubTator, text mining | PubMed |
| Bioinformatics Tools for the Analysis of Active Compounds Identified in Ranunculaceae Species. | Pharmaceuticals (Basel) | 2023 | 37375790 | PubTator, text mining | PubMed |
| Probenecid, an Old Drug with Potential New Uses for Central Nervous System Disorders and Neuroinflammation. | Biomedicines | 2023 | 37371611 | PubTator, text mining | PubMed |
| Advances in Genetics and Epigenetics of Developmental Coordination Disorder in Children. | Brain Sci | 2023 | 37371418 | PubTator, text mining | PubMed |
| Potential herb‒drug interactions between anti-COVID-19 drugs and traditional Chinese medicine. | Acta Pharm Sin B | 2023 | 37360014 | PubTator, text mining | PubMed |
| Pharmacokinetics and Drug-Drug Interaction of Ocedurenone (KBP-5074) in vitro and in vivo. | Eur J Drug Metab Pharmacokinet | 2023 | 37357226 | PubTator, text mining | PubMed |
| High rates of kidney impairment among older people (≥ 60 years) living with HIV on first-line antiretroviral therapy at screening for a clinical trial in Kenya. | PLoS One | 2023 | 37352206 | PubTator, text mining | PubMed |
| A report of a pedigree with compound heterozygous mutations in the SLC22A5 gene. | Front Pediatr | 2023 | 37351314 | PubTator, text mining | PubMed |
| 3D vascularised proximal tubules-on-a-multiplexed chip model for enhanced cell phenotypes. | Lab Chip | 2023 | 37341452 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6582/papers?page=12